Derived From Cannabis, Pt. 5 Tetrahydrocannabivarin (THCV)

January 30, 2013

 

I have already told you about four cannaboids that could be in use and could definitely be researched more to fetermine what other healing properties and uses could benefit us.   Discovered in 1970, tetrahydrocannabivarin (THCV) is most typically identified in Pakistani hashish and cannabis strains of southern African origin. Depending on the dose, THCV may either antagonize some of the therapeutic effects of THC (e.g., at low doses THCV may repress appetite) or promote them. (Higher doses of THCV exerting beneficial effects on bone formation and fracture healing in preclinical models, for example.) Unlike, CBD, CBN, CBC, CBG, high doses of THCV may also be mildly psychoactive (but far less so than THC).
 
To date, fewer than 30 papers available on PubMed specifically reference THCV. Over half of these were published within the past three years. Some of these more recent studies highlight tetrahydrocannabivarin’s anti-epileptic and anticonvulsant properties, as well as its ability to mitigate inflammation and pain – in particular, difficult-to-treat neuropathy.
 
Like CBD, THCV is on the radar of British biotech GW Pharmaceuticals (makers of Sativex). According to its website, the company has expressed interest in the potential use of tetrahydrocannabivarin in the treatment of obesity, diabetes and other related metabolic disorders. Though the compound has been subject to Phase I clinical testing, a keyword search on clinicaltrials.gov yields no specific references to any ongoing studies at this time.

It's quite disgusting that our government is more than aware of the therapeutic properties of the cannaboid compunds found in cannabis and yet they do mre than turn a blind eye.  They have patented and criminalized cannabis and all of it's derivatives.  Does our government really have it's citizens best interest in mind?